225 related articles for article (PubMed ID: 12200758)
1. Increased rates of lipolysis among human immunodeficiency virus-infected men receiving highly active antiretroviral therapy.
Hadigan C; Borgonha S; Rabe J; Young V; Grinspoon S
Metabolism; 2002 Sep; 51(9):1143-7. PubMed ID: 12200758
[TBL] [Abstract][Full Text] [Related]
2. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution.
Meininger G; Hadigan C; Laposata M; Brown J; Rabe J; Louca J; Aliabadi N; Grinspoon S
Metabolism; 2002 Feb; 51(2):260-6. PubMed ID: 11833059
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution.
Hadigan C; Rabe J; Meininger G; Aliabadi N; Breu J; Grinspoon S
Am J Clin Nutr; 2003 Feb; 77(2):490-4. PubMed ID: 12540412
[TBL] [Abstract][Full Text] [Related]
4. Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome.
Torriani M; Hadigan C; Jensen ME; Grinspoon S
J Appl Physiol (1985); 2003 Sep; 95(3):1005-10. PubMed ID: 12766180
[TBL] [Abstract][Full Text] [Related]
5. Blunted lipolysis and fatty acid oxidation during moderate exercise in HIV-infected subjects taking HAART.
Cade WT; Reeds DN; Mittendorfer B; Patterson BW; Powderly WG; Klein S; Yarasheski KE
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E812-9. PubMed ID: 17106066
[TBL] [Abstract][Full Text] [Related]
6. Effects of rosiglitazone on abnormal lipid kinetics in HIV-associated dyslipidemic lipodystrophy: a stable isotope study.
Sekhar RV; Patel SG; D'Amico S; Shi J; Balasubramanyam A; Rehman K; Jahoor F; Visnegarwala F
Metabolism; 2011 Jun; 60(6):754-60. PubMed ID: 20832829
[TBL] [Abstract][Full Text] [Related]
7. Markedly diminished lipolysis and partial restoration of glucose metabolism, without changes in fat distribution after extended discontinuation of protease inhibitors in severe lipodystrophic human immunodeficient virus-1-infected patients.
van der Valk M; Allick G; Weverling GJ; Romijn JA; Ackermans MT; Lange JM; van Eck-Smit BL; van Kuijk C; Endert E; Sauerwein HP; Reiss P
J Clin Endocrinol Metab; 2004 Jul; 89(7):3554-60. PubMed ID: 15240645
[TBL] [Abstract][Full Text] [Related]
8. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.
Haugaard SB; Andersen O; Pedersen SB; Dela F; Fenger M; Richelsen B; Madsbad S; Iversen J
Metabolism; 2006 Feb; 55(2):175-82. PubMed ID: 16423623
[TBL] [Abstract][Full Text] [Related]
10. Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.
Estrada V; Serrano-Ríos M; Martínez Larrad MT; Villar NG; González López A; Téllez MJ; Fernández C
J Acquir Immune Defic Syndr; 2002 Jan; 29(1):32-40. PubMed ID: 11782587
[TBL] [Abstract][Full Text] [Related]
11. Serum lipids, glucose homeostasis and abdominal adipose tissue distribution in protease inhibitor-treated and naive HIV-infected children.
Bitnun A; Sochett E; Babyn P; Holowka S; Stephens D; Read S; King SM
AIDS; 2003 Jun; 17(9):1319-27. PubMed ID: 12799553
[TBL] [Abstract][Full Text] [Related]
12. Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.
Gibney J; Healy ML; Stolinski M; Bowes SB; Pentecost C; Breen L; McMillan C; Russell-Jones DL; Sonksen PH; Umpleby AM
J Clin Endocrinol Metab; 2003 Apr; 88(4):1792-7. PubMed ID: 12679475
[TBL] [Abstract][Full Text] [Related]
13. A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy.
Blümer RM; van der Valk M; Ackermans M; Endert E; Serlie MJ; Reiss P; Sauerwein HP
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1097-104. PubMed ID: 19690066
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipolysis stimulates peripheral glucose uptake but has no effect on endogenous glucose production in HIV lipodystrophy.
Lindegaard B; Frøsig C; Petersen AM; Plomgaard P; Ditlevsen S; Mittendorfer B; Van Hall G; Wojtaszewski JF; Pedersen BK
Diabetes; 2007 Aug; 56(8):2070-7. PubMed ID: 17601993
[TBL] [Abstract][Full Text] [Related]
16. In nondiabetic, human immunodeficiency virus-infected patients with lipodystrophy, hepatic insulin extraction and posthepatic insulin clearance rate are decreased in proportion to insulin resistance.
Haugaard SB; Andersen O; Hansen BR; Andersen UB; Vølund A; Iversen J; Nielsen JO; Madsbad S
Metabolism; 2005 Feb; 54(2):171-9. PubMed ID: 15690310
[TBL] [Abstract][Full Text] [Related]
17. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
Rao MN; Mulligan K; Tai V; Wen MJ; Dyachenko A; Weinberg M; Li X; Lang T; Grunfeld C; Schwarz JM; Schambelan M
J Clin Endocrinol Metab; 2010 Sep; 95(9):4361-6. PubMed ID: 20610601
[TBL] [Abstract][Full Text] [Related]
18. Metabolic basis of HIV-lipodystrophy syndrome.
Sekhar RV; Jahoor F; White AC; Pownall HJ; Visnegarwala F; Rodriguez-Barradas MC; Sharma M; Reeds PJ; Balasubramanyam A
Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E332-7. PubMed ID: 12110539
[TBL] [Abstract][Full Text] [Related]
19. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
[TBL] [Abstract][Full Text] [Related]
20. Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients.
Lindegaard B; Keller P; Bruunsgaard H; Gerstoft J; Pedersen BK
Clin Exp Immunol; 2004 Feb; 135(2):273-9. PubMed ID: 14738456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
